SCHEMBL5283894

SCHEMBL5283894

Cc1cc(CC(=O)Oc2c(F)c(F)c(F)c(F)c2F)on1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VHL P40337 2/20 0.49
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 3/20 0.38
HCAR2 Q8TDS4 1/20 0.38
EPHX2 P34913 2/20 0.36
P2RX7 Q99572 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
POLB P06746 1/20 0.35
TSHR P16473 1/20 0.34
RAB9A P51151 2/20 0.34
NPC1 O15118 1/20 0.34
NAMPT P43490 1/20 0.34
GLA P06280 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5281369 0.81 EPHX2 (0.40) VHLALDH1A1EPHX2SMN1; SMN2RAB9A
SCHEMBL5287986 0.79 SMN1; SMN2 (0.37) VHLALDH1A1SMN1; SMN2TSHRRAB9A
SCHEMBL1136794 0.79 VHL (0.59) VHLMEN1KMT2AALDH1A1HCAR2
SCHEMBL5286842 0.78 NOTUM (0.51) ALDH1A1SMN1; SMN2POLBRAB9ANPC1
SCHEMBL4751904 0.78 VHL (0.54) VHLMEN1KMT2AALDH1A1HCAR2
SCHEMBL4093165 0.73 VHL (0.60) VHLMEN1KMT2AALDH1A1HCAR2
SCHEMBL6251 0.73 VHL (0.60) VHLMEN1KMT2AALDH1A1HCAR2
SCHEMBL314857 0.72 VHL (0.58) VHLMEN1KMT2AALDH1A1HCAR2
SCHEMBL6709129 0.72 VHL (0.58) VHLMEN1KMT2AALDH1A1HCAR2
Hydrochloric Acid SCHEMBL1375734 0.72 VHL (0.58) VHLMEN1KMT2AALDH1A1HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007001335-A2 RAMOPLANIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS INC. (US) 2007-01-04 WO disclosed
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity VICURON PHARMACEUTICALS INC. (US) 2006-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity CLSPN, LMAN2, RPN2 VHL 4053/4885MEN1 2853/4885KMT2A 4422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.